Skip to main content
. 2021 Jul 26;26:1605. doi: 10.4102/hsag.v26i0.1605

TABLE 1.

Characteristics of participants.

Variable CMF regimen % FAC regimen % p
Mean age 53.80 - 48.05 - 0.05*
Age range - - - - 0.12
31–50 02 20 11 55
51–60 08 80 09 45
Ethnic group
Black African 10 33 20 67
Marital status - - - - -
Married 04 40 08 40
Divorced 02 20 03 15
Separated 00 00 01 05
Widowed 01 10 05 25
Single 03 30 03 15
Employment status - - - - -
Unemployed 07 70 12 60
Full-time 02 20 02 10
Part-time 01 10 06 30
Educational level - - - - 0.15
Lower primary 00 00 00 00
Primary 01 10 01 05
Middle school 03 30 05 25
High school 04 40 14 70
Post school 02 20 00 00
Breast cancer stage - - - - 1.00
II 04 40 08 40
III 06 60 12 60

CMF, Cyclophosphamide, methotrexate, fluorouracil; FAC, fluorouracil, adriamycin, cyclophosphamide.

Fisher exact tests.

*

, Significance level set as p < 0.05.